Dublin, Ireland, November 19th 2007 - AGI Therapeutics plc (“AGI” or the “Company”) (AIM, IEX: AGI), the speciality pharmaceutical company focused on gastrointestinal drug products, today announces that the Company’s Chief Executive Officer, Dr. John Devane, will make a presentation at the 19th Annual Piper Jaffray Health Care Conference in New York.
